Status report
Get it in writing
The official USPTO status record for IDACIO, serial 97373891, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
IDACIOSerial 97373891 · Principal Register
Live · Registered
Owner: Fresenius Kabi Deutschland GmbH
Class 005 - Pharmaceuticals
Filed Apr 21, 2022
Registered Sep 26, 2023
The record shows that the mark IDACIO is live and registered on the Principal Register, with Fresenius Kabi Deutschland GmbH listed as the owner. It covers pharmaceutical preparations for human use, specifically treatments for neurological, immunological, inflammatory, oncological and viral conditions, as well as a range of autoimmune and inflammatory disorders such as plaque psoriasis, rheumatoid arthritis and Crohn’s disease. Because the listed goods are narrowly focused on medical drugs, a similar name used for unrelated products would be a farther concern, but a comparable name in the pharmaceutical field would present the closest record‑based risk. The record does not give the owner control over every possible use of the word “IDACIO.” The most recent meaningful event is the registration date of September 26 2023, and the supplied history shows no oppositions, cancellations or other enforcement activity. I'd treat this as a meaningful concern if you plan a pharma‑related brand using a similar name.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.